Morteza Hafezi
Ludwig Cancer Research(CH)
Publications by Year
Research Areas
Immune Cell Function and Interaction, CAR-T cell therapy research, Immunotherapy and Immune Responses, Hepatitis B Virus Studies, CRISPR and Genetic Engineering
Most-Cited Works
- → SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls(2020)2,143 cited
- → Osteoclast activation in inflammatory periodontal diseases(1996)69 cited
- → Immunosuppressive Drug‐Resistant Armored T‐Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients(2020)56 cited
- → Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individuals(2020)37 cited
- → Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia(2019)36 cited
- Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.(2018)
- → Dual ON/OFF-switch chimeric antigen receptor controlled by two clinically approved drugs(2024)12 cited
- → T cell receptor precision editing of regulatory T cells for celiac disease(2025)5 cited
- → Personalized Armored TCR-Redirected T Cell Therapy for Liver/Organ Transplant with Recurrent Cancer(2021)4 cited
- → Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer(2025)3 cited